Merlin Crossley

Merlin Crossley

Auto-generated profile, based on publicly available information

Merlin Crossley

School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, Australia

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 1997 in Cell
Verified
Journal Article
Closed access
ATAlice P Tsang
Alice P Tsang
JVJane E Visvader
Jane E Visvader
CTC.Alexander Turner
C.Alexander Turner
YFYuko Fujiwara
Yuko Fujiwara
CYChanning Yu
Channing Yu
SOStuart H Orkin
Stuart H Orkin

1 February 2007 in Trends in Biochemical Sciences
Verified
Journal Article
Closed access
RGRoland Gamsjaeger
Roland Gamsjaeger
CLC Liew
C Liew
FLF Loughlin
F Loughlin
MCM Crossley
M Crossley
JMJ Mackay
J Mackay

1 January 1998 in Trends in Biochemical Sciences
Verified
Journal Article
Closed access
JMJoel P. Mackay
Joel P. Mackay
MCMerlin Crossley
Merlin Crossley

1 February 2003 in EMBO Reports
Verified
Journal Article
Open access
PDF file
AVAlexis Verger
Alexis Verger
JPJose Perdomo
Jose Perdomo
MCMerlin Crossley
Merlin Crossley
Small ubiquitin‐related modifier (SUMO) is a protein moiety that is ligated to lysine residues in a variety of target proteins. The addition of SUMO can modulate the ability of proteins to interact with their partners, alter their patterns of subcellular localization and control their stability. It is clear that SUMO influences many different biological processes, but recent data suggest that it is particularly important in the regulation of transcription. Indeed, several transcription factors, such as Sp3, c‐Jun, c‐Myb and various nuclear receptors, have recently been shown to be subject to sumoylation and, although this modification can have a positive influence, a growing body of evidence highlights its role in the negative regulation of transcription. This review summarizes recent experiments focusing on sumoylation and transcriptional repression.

15 January 2016 in Science
Verified
Journal Article
Closed access
PDF file
TMTakeshi Masuda
Takeshi Masuda
XWXin Wang
Xin Wang
MMManami Maeda
Manami Maeda
MCMatthew C. Canver
Matthew C. Canver
FSFalak Sher
Falak Sher
TMTakahiro Maeda
Takahiro Maeda
Reactivating the fetal globin gene: Mutation of adult-type globin genes causes sickle cell disease and thalassemia. Although treating these hemoglobinopathies with gene therapy is possible, there is a pressing need for pharmacologic approaches to treat general patient populations. One promising approach is to reactivate repressed expression of fetal-type hemoglobin (HbF) in adult erythroid cells. Masuda et al. reveal a molecular mechanism governing HbF repression as mediated by the LRF/ZBTB7A transcription factor. The study may encourage the development of new HbF reactivation therapies for hemoglobinopathies. Science , this issue p. 285

1 January 2008 in The International Journal of Biochemistry & Cell Biology
Verified
Journal Article
Closed access
RPRichard Pearson
Richard Pearson
JFJacqueline Fleetwood
Jacqueline Fleetwood
SESally Eaton
Sally Eaton
MCMerlin Crossley
Merlin Crossley
SBShisan Bao
Shisan Bao